Auro Laboratories Ltd. Share Price & Stock Analysis

Auro Laboratories Ltd. (BSE: 530233) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹145 Cr, it ranks #2,927 by market cap among the 6,197 Indian listed companies on FinBizNet, and #61 of 86 in Medicinal Chemicals and Botanical Products. At ₹234.50 (as of 16 Nov 2026), the share price is 26.0% below its 52-week high of ₹317.00 and 17.3% above its 52-week low of ₹199.95. The share price is up 25.4% over one year and down 2.4% over three months.

Key Metrics

Current Price₹234.50
Market Cap₹145 Cr
BSE Code530233
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio41.2
Return on Equity7.91%
Return on Assets4.20%
52-Week Range₹199.95 – ₹317.00
1-Year Price Change+25.4%
3-Month Price Change-2.4%
Beta (1Y)0.24
HeadquartersMumbai, Maharashtra
Websitewww.aurolabs.com

Shareholding and Delivery

Delivery averaged 74.0% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Auro Laboratories Ltd.

Auro Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs), intermediates, and generic formulations in India. It offers antihistamine; muscle relaxant; diuretic; iron deficiency; anti-diabetic, including Metformin HCL; anti-fungal, ulcer, malaria, and inflammatory; iodine supplement; analgesics; antacids; potassium and sodium iodide; and microcrystalline cellulose. The company also provides specialty chemicals comprising guanidine nitrate; dimethyl amine HCl; 2-ethoxy benzoic acid; and 3,4,5 - trimethoxy benzoic acid. In addition, it offers intermediates consisting of glibenclamde sulphonamide for use in API glibenclamide; cis-bramo benzoate and cls-tosylate that are used in API Ketoconazol; 3,4,5 - trimethoxy benzoic acid; 2-ethoxy benzoic acid for use in API sildenafil citrate; and 5-bromo phthalide that is used in API citalopram. It also exports products to Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain, and the United Kingdom. The co

Products and Services

1. Pharmaceuticals-This segment manufactures and sells generic active pharmaceutical ingredients.

Business Segments

1. Pharmaceuticals-100%

Auro Laboratories Ltd. vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Auro Laboratories Ltd.₹145 Cr41.27.91%—+25.4%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Auro Laboratories Ltd.?

Auro Laboratories Ltd. is trading at ₹234.50, with a market capitalisation of ₹145 Cr.

Which sector does Auro Laboratories Ltd. belong to?

Auro Laboratories Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Auro Laboratories Ltd.?

Auro Laboratories Ltd. has a P/E of 41.2 and a return on equity of 7.91%.

What is the stock symbol of Auro Laboratories Ltd.?

Auro Laboratories Ltd. is listed on the BSE under the scrip code 530233.

How has Auro Laboratories Ltd.'s share price moved over the past year?

Auro Laboratories Ltd.'s share price is up 25.4% over one year and down 2.4% over three months. Its 52-week range is ₹199.95 to ₹317.00.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.